Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ross I Baker

Showing results (11-20 of 53) with videos related to

Pageof 6
Sort By:
Arteriosclerosis, Thrombosis, and Vascular Biology|April 4, 2015
Current state and novel approaches of antiplatelet therapyPat Metharom, Michael C Berndt, Ross I Baker, et al.
Journal of Thrombosis and Haemostasis : JTH|March 5, 2026
Recommendation to adopt the Type 1C VWD nomenclature into the classification of von Willebrand disease: Communication from the ISTH SSC Subcommittee on von Willebrand Factor (VWF)Christopher J Ng, Ross I Baker, Michelle Lavin, et al.
Immunological Reviews|October 27, 2015
The platelet Fc receptor, FcγRIIaJianlin Qiao, Mohammad Al-Tamimi, Ross I Baker, et al.
Journal of Thrombosis and Thrombolysis|August 6, 2005
Once-daily enoxaparin in the outpatient setting versus unfractionated heparin in hospital for the treatment of symptomatic deep-vein thrombosisBeng H Chong, Tim A Brighton, Ross I Baker, et al.
Molecules (Basel, Switzerland)|October 20, 2017
Construction of a Bivalent Thrombin Binding Aptamer and Its Antidote with Improved PropertiesQuintin W Hughes, Bao T Le, Grace Gilmore, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|September 25, 2007
Polymorphisms in the tissue factor pathway inhibitor gene are not associated with ischaemic strokeMilly S Sayer, Vanessa J Cole, Murray J Adams, et al.
Journal of Thrombosis and Haemostasis : JTH|June 12, 2024
Examining variability in the diagnosis and management of people with bleeding disorders of unknown cause: communication from the ISTH SSC Subcommittee on von Willebrand FactorClaire Kelly, Will Thomas, Ross I Baker, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|September 1, 2007
Polymorphisms of the tissue factor pathway inhibitor gene are associated with venous thromboembolism in the antiphospholipid syndrome and carriers of factor V LeidenLisa F Lincz, Murray J Adams, Fiona E Scorgie, et al.
The Medical Journal of Australia|November 2, 2004
Warfarin reversal: consensus guidelines, on behalf of the Australasian Society of Thrombosis and HaemostasisRoss I Baker, Paul B Coughlin, Alex S Gallus, et al.
Stroke|August 9, 2003
Endothelial and platelet activation in acute ischemic stroke and its etiological subtypesPaul Cherian, Graeme J Hankey, John W Eikelboom, et al.
Pageof 6

Showing results (11-20 of 53) with videos related to

Sort By:
Pageof 6
Arteriosclerosis, Thrombosis, and Vascular Biology|April 4, 2015
Current state and novel approaches of antiplatelet therapyPat Metharom, Michael C Berndt, Ross I Baker, et al.
Journal of Thrombosis and Haemostasis : JTH|March 5, 2026
Recommendation to adopt the Type 1C VWD nomenclature into the classification of von Willebrand disease: Communication from the ISTH SSC Subcommittee on von Willebrand Factor (VWF)Christopher J Ng, Ross I Baker, Michelle Lavin, et al.
Immunological Reviews|October 27, 2015
The platelet Fc receptor, FcγRIIaJianlin Qiao, Mohammad Al-Tamimi, Ross I Baker, et al.
Journal of Thrombosis and Thrombolysis|August 6, 2005
Once-daily enoxaparin in the outpatient setting versus unfractionated heparin in hospital for the treatment of symptomatic deep-vein thrombosisBeng H Chong, Tim A Brighton, Ross I Baker, et al.
Molecules (Basel, Switzerland)|October 20, 2017
Construction of a Bivalent Thrombin Binding Aptamer and Its Antidote with Improved PropertiesQuintin W Hughes, Bao T Le, Grace Gilmore, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|September 25, 2007
Polymorphisms in the tissue factor pathway inhibitor gene are not associated with ischaemic strokeMilly S Sayer, Vanessa J Cole, Murray J Adams, et al.
Journal of Thrombosis and Haemostasis : JTH|June 12, 2024
Examining variability in the diagnosis and management of people with bleeding disorders of unknown cause: communication from the ISTH SSC Subcommittee on von Willebrand FactorClaire Kelly, Will Thomas, Ross I Baker, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|September 1, 2007
Polymorphisms of the tissue factor pathway inhibitor gene are associated with venous thromboembolism in the antiphospholipid syndrome and carriers of factor V LeidenLisa F Lincz, Murray J Adams, Fiona E Scorgie, et al.
The Medical Journal of Australia|November 2, 2004
Warfarin reversal: consensus guidelines, on behalf of the Australasian Society of Thrombosis and HaemostasisRoss I Baker, Paul B Coughlin, Alex S Gallus, et al.
Stroke|August 9, 2003
Endothelial and platelet activation in acute ischemic stroke and its etiological subtypesPaul Cherian, Graeme J Hankey, John W Eikelboom, et al.
Pageof 6